Leveraging Northway Biotech’s 20+ years of CDMO expertise, Diorasis Therapeutics is advancing AAV gene therapy for glaucoma ...

An experimentation in Dori work, antique textiles and smart draping, the collection saw both male and female models walk down in reimaginings of the khada dupatta. Titled Reclaimed Opulence, Reddy ...

Aims: This study describes a prospective consecutive case series of the initial six eyes of five patients undergoing implantation of the trabecular bypass tube shunt. Methods: A prospective ...

Cost-Utility Analysis published in the Expert Review of Pharmacoeconomics and Outcomes Research ...

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

Now we can move into the clinical decisions that guide MIGS choice. We have good evidence that glaucoma begins as a disease in the trabecular meshwork.

Research on MXene-ECM scaffolds reveals their potential in enhancing electrical stimulation for neural repair, crucial for ...

Within the treated group, eyes with plus disease had consistently lower C/D values than those without plus disease, a finding the study authors say may result from obscuring of the optic cup by ...

Women scientists and clinicians have played a transformative role in driving innovation, discovery, and clinical excellence ...

Nethradhama launches Mysuru’s First Minimally Invasive Glaucoma Surgery (MIGS) Center of Excellence: Our Bureau, Bengaluru Friday, July 18, 2025, 12:45 Hrs [IST] Nethradhama Sup ...

Experimental Er:YAG laser photoablation of the trabecular meshwork in rabbits: an in vivo study. Exp Eye Res 1997; 64:701–6 Article CAS Google Scholar Dietlein TS, Jacobi PC, Krieglstein GK .